Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination.
Abdulrahman RM, Verloop H, Hoftijzer H, Verburg E, Hovens GC, Corssmit EP, Reiners C, Gelderblom H, Pereira AM, Kapiteijn E, Romijn JA, Visser TJ, Smit JW.
Abdulrahman RM, et al.
J Clin Endocrinol Metab. 2010 Aug;95(8):3758-62. doi: 10.1210/jc.2009-2507. Epub 2010 May 19.
J Clin Endocrinol Metab. 2010.
PMID: 20484486
Clinical Trial.